Key Record Dates
ClinicalTrials.gov Identifier: | NCT04101331 |
---|---|
Brief Title: | Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides (REDIRECT) |
First Submitted : | September 20, 2019 |
First Submitted that Met QC Criteria : | September 23, 2019 |
First Posted : | September 24, 2019 |
Results First Submitted : | May 8, 2023 |
Results First Submitted that Met QC Criteria : | May 8, 2023 |
Results First Posted : | June 5, 2023 |
Last Update Submitted that Met QC Criteria : | January 31, 2024 |
Last Update Posted : | February 2, 2024 |